• Although a role for renin in the pathogenesis of acute and chronic experimental renal hypertension has been established in dogs by the use of specific antibodies to exclude its action, 2 parallel studies in primates have not been reported. When a hog kidney extract containing renin is injected into dogs an antibody (antirenin) is produced which blocks the acute pressor effect of dog as well as hog renin. A course of intramuscular injections of hog renin in chronic renal hypertensive dogs produces an antihypertensive effeet which is well correlated with the antirenin titer of the serum. A course of hog renin injections in normotensive dogs prevents the development of an elevation of blood pressure after renal artery constriction, provided a minimum effective titer of antirenin to hog renin has been produced. Similarly, passive transfer of antirenin to hog renin into renal hypertensive dogs is associated with decreases of blood pressure to or toward normotension which are well correlated with the antirenin titer. 3 Certain general features of experimental renal hypertension in one primate, the monkey, have already been described 4 ' 5 and at-From the Department of Physiology, University of Illinois College of Medicine, Chicago, Illinois.
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Circvlalion Research. Volume XII, March 196, 1 tempts at treating essential hypertension in humans with hog renin have also been reported. 6 -7 In the present study an effort has been made to examine the role of renin in experimental renal hypertension in the monkey and to compare the antihypertensive effectiveness of antirenin in the dog and in the monkey under various circumstances. Data have also been recorded on the sequelae of long maintained hypertension in the monkey.
Methods

EXPERIMENTAL PROCEDURES ON MONKEYS
The monkeys were kp.pt in a room held to a temperature of 27° C and fed a daily diet consisting of whole wheat bread, an apple, an orange, and a banana. This daily diet was supplemented by iin oral multivitamin preparation." Carrots, lettuce or peanuts were fed occasionally. During the latter part of the study, 16 g of cooked, ground horsemeat and three g of lard were also included in the daily diet.
Mean femoral arterial blood pressure was obtained by direct arterial puncture. Blood pressure was read on an aneroid manometer, which was checked against a standard mercury manometer. As a rule, blood pressures were determined weekly on each monkey. During the week after administration of antiserum to an animal there were four determinations of pressure. It was found that monkeys which were fatigued or injured while struggling before blood pressure determinations frequently registered low pressures. For this reason, the determination of blood pi-essure in an animal was not performed after such a struggle and the interval between determinations frequently extended to two weeks.
In most cases, the renal artery was constricted *Five ml of "Vi-Daylin" (Abbott).
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FKANK by a small silver clarnp o£ the type designed by Goldblatt. 8 The internal diameter of the clamp was two millimeters. 4 The clamp as used in this laboratory was modified by a locknut which served to maintain a desired degree of constriction. 2 Careful preoperative and postoperative care was necessary. Diarrhea and prolonged anorexia were frequent postoperative oomplieations although they did not affect the development of hypertension. Sodium pentobarbital, which has been found highty satisfactory for the monkey, 0 was used as the anesthetic. The renal artery was exposed by a lumbar retroperitoneal approach. The setting of the clamp on the renal artery was determined by the ratio of the palpable volume pulse proximal and distal to the clamp. The setting was then fixed by the locknut. Relaxation of the wall of the artery was assured by the application of a buffered 1% procaine solution. The aperture necessary for a 3:1 constriction was found to be relatively constant for a given weight of animal and roughly proportional to the weight of the kidney. 1 The right renal artery was constricted first, three weeks usually before constriction of the left renal artery. In some cases the second operation was a nephrectomy and in other cases the second kidney was left untouched. Protective measures against tuberculosis followed the recommendations of Habel 10 and Ratcliffe 11 and are described elsewhere in detail. 1
PREPARATION OF RENIN*
Crude hog renin was prepared by saline extraction in the cold of acetone-ether desiccated, defatted kidney powder. This was followed by removal of much extraneous protein by precipitation at pH 4.0. The preparation of crude dog' renin included a further step with precipitation of the crude renin bv ammonium sulfate. The usual purity was 1 Goldblatt dog-unit (D.U.)/mg N for crude hog renin and 5 D.U./rag ! ST for crude dog renin. Crude extracts of human liver or monkey muscle were prepared by the same method as crude hog renin.
In the earlier experiments, semipurified hog renin (approximately 100 D.U./rag N) was prepared from crude renin by the method of Marshall and Wakerlin. 12 Semipurified hog renin for later experiments was prepared by a modification of the method of Haas et al. 13 Human renin was prepared from kidneys made available from hospitals in the Chicago area. Autopsy material was pooled, stored, and sorne-*Dr. Leonard A. Graham, Instructor in Pharmacology, The Bowman Gray School of Medicine, prepared the renin used in these experiments and adapted published procedures on renin purification to the purposes of this study. times frozen before it became available for extraction. About ten thousand human kidneys were used. Human renin for the earlier experiments was prepared by the method for crude hog or dog renin. This preparation had a purity of only 0.03 D.U./mg N. The human renin used in subsequent experiments was purified further. 1 This method gave renin at a purity of 1 D.U./mg N at a yield of 0.04 DU./g of tissue. The human renin usually showed evidence of bacterial contamination and Seitz nitration was necessary before injection.
In view of the very low yields of human renin, the semipurified hog renin used in a mimher of experiments was subjected to chemical pro-treatment in unsuccessful efforts to modify its antigenicity. 1
PREPARATION OF ANTIRENIN
Antirenin was obtained by regular bleedings from dogs which had been injected daily with hog renin or human renin. Blood was drawn under sterile conditions into a bottle containing heparin and centrifuged in the cold. Then, the plasma was frozen. Several days before the anticipated use, the plasma was thawed and filtered in the cold to remove fibrin clots. A blood agar plate was streaked and incubated to give evidence of possible contamination. Control sera were prepared by the same procedure. Serum was administered under sterile conditions into the loose subcutaneous tissues of the axilla, the abdomen, or the groin. In early experiments the serum was administered in a single dose. Later the serum was administered in four parts over two days. Blood pressures were determined and antirenin samples obtained on the first, third, fifth and seventh days after the administration of serum was begun.
BIOASSAY METHODS
Assay for ienin and antirenin was performed in nephreetomized dogs under ether anesthesia. Each determination was made on two or more dogs. Samples of blood were drawn for determination of antirenin titer at weekly to monthly intervals from animals injected with renin. Antirenin titers were expressed in antirenin units (A.U.)/rnl of serum, one A.U. being twice the amount which would half neutralize the pressor effect of one D.U. of renin.
Monkey kidneys were prepared for assay of renin content by cutting them into small pieces and defatting and dehydrating them in acetone and ether. The material was then dried and ground into a coarse powder. Crude renin was extracted by allowing the powder to stand overnight in sterile saline. The mixture was then strained through gauze and extraneous protein removed by precipitation at pH 4.0.
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Results
The results of this study are presented in four main categories: Species specificity of renin and antirenin; production of experimental renal hypertension; antihypertensive eif ects of rerun and antirenin; and clinical, pathologic and miscellaneous observations.
SPECIES SPECIFICITY OF RENIN AND ANTIRENIN
Human and monkey renins evoked a pressor response in the monkey while infra primate renins did not. (An acute experiment in an ether-anesthetized 5.0 kilogram monkey showed that 0.25 D.U. of crude human or crude monkey renin produced a rise in blood pressure of 15 to 20 mm Hg while 200 units of semipurified hog reniu failed to produce any effect. One hundred D.U. each of crude dog and crude rabbit renin were depressor.) It follows that human and monkey renins are more closely related to each other than to the renins from infraprimate species. This conclusion is supported by the observation (in ether-anesthetized dogs) that human and monkey renins are equally neutralized by antirenin to human renin, while renins from infraprimate species (such as the hog or dog) are not neutralized. The species in which the antirenin was produced (dog, goat, or monkey) did not matter.
PRODUCTION OF EXPERIMENTAL RENAL HYPERTENSION
The untreated monkeys whose renal arteries were constricted bilaterally at a 3:1 volume pulse ratio form a control group for one subcategory of our experiments. This pulse ratio produced hypertension in every untreated animal. An example of the development of hypertension after constriction is shown in figure  4d .
The results of constriction of the right renal artery at a 3:1 ratio in seventeen healthy monkeys are summarized on the left side of figure 3c . The right side of figure 3c summarizes the results of 3 :1 constriction of the left renal artery in nine monkeys three to nine weeks later. In eight of the nine monkeys the second constriction was followed by further increases in blood pressure during the 28-day postoperative period shown in the figure. The mean weight of these animals declined by 0.3 kg from 6.1 kg-an insignificant change. There was no relationship evident between sex or weight and the development of hypertension.
In four of the seventeen monkeys the second operation was contralateral nephrectomy. This procedure was also followed by a further increase in blood pressure (example in fig.  lb ). In three of the seventeen monkeys the second kidney was left untouched. In two of these (monkeys 17 and 18), hypertension was maintained. At the end of the period of observation (35 and 26 months after constriction) they had hypertensions of 50 and 60 mm Hg (figs, la and 2a). The blood pressure of the third monkey decreased to normotension, however, within four months after unilateral constriction. The second kidney was left untouched in two additional animals which were not part of this control group, inasmuch as they had received renin before constriction. These animals also developed stable hypertensions (60 and 65 mm Hg).
ANTIHYPERTENSIVE EFFECT OF RENIN AND ANTIRENIN
The observations in this categoiy include treatment of existing experimental renal hypertension and prophylaxis against the development of experimental renal hypertension.
Treatment of Experimental Renal Hypertension
Treatment was undertaken both with renin and antirenin. Active therapy was performed with human and hog renins. Passive treatment was carried out with antiserum containing antirenin to human renin or antirenin to hog renin.
Active Treatment with Renin 1. Crude human renin and crude liver extract. Attempts to treat existing experimental renal hypertension in monkeys with crude human renin were partially successful in four experiments (table 1). In every case blood pressure decreased from halfway to one-third of the way to normotension when antirenin to human renin appeared in the plasma in titers 
U./ml or over. When antirenin disappeared from the plasma after injections were discontinued, the blood pressure returned to the original hypertensive level. There was no evidence for an interfering effect of renal medulla, previously reported for the treatment of experimental renal hypertension in the dog with hog renin. 2 The antihypertensive response of monkey 17 (fig. l a ) , the only monkey in the group injected with human renin from whole kidney, was as great as that of any other monkey in the group. In the three treatment experiments with crude human renin from cortex there was no correlation evident between the antihypertensive responses and the antirenin titers.
In the two control experiments, shown on table 1, a human liver extract was injected daily. After three months of injections changes in blood pressure were still not observed although the daily dose of human protein was four to fifteen times greater than that administered during the experiments with human renin.
2. Semipurified hog renin. Antihypertensive responses were not observed during any of the treatment experiments in which semipurified hog renin (or the same treated chemically) was administered. In four experiments with semipurified hog renin from cortex the animals were treated for two to eight months with maximum daily doses of two to 20 D.U./kg before maximum antirenin titers of 17 to 80 A.U./ml to hog renin were obtained. Neutralization of human renin by the antisera was not observed. Figure lb illustrates a representative experiment.
In eight experiments with semipurified hog renin treated chemically maximum antirenin titers of 2.1 to 43 A.U./ml to hog renin were produced. Repeated assay determinations failed to reveal any neutralization of human renin.
The difference between the results with human renin and those with hog renin were significant, according to a comparison made on an occurrence, non-occurrence basis, between the experiments where maximum titers 9f tThe experiment in monkey 56 was considered negative although the lowest blood pressure recorded during the week after administration of serum was substantially lower than the control pressures. The lowest pressure was recorded on the sixth day, after a week of pressures which were not remarkable.
JNotes on the experiments performed in monkeys 32 and 39 are included in the text. of 0.8 to 12 A.U./ml to human renin developed and the experiments in which maximum titers o£ ]3 to 80 A.U./ml to hog reniu developed (P = 0.003). 1
Passive Treatment with Antirenin
Eighteen monkeys, fourteen of which were hypertensive, received dog serum in 64 experiments and monkey serum in two experiments. The experiments with monkey serum and the initial experiments with dog serum are summarized in table 2.
1. Aniirenin to human renin. When antirenin to human renin was administered passively to renal hypertensive monkeys (upper third of table 2) the antihypertensive effects were substantially more marked than in monkeys in which the antirenin titers were produced by daily injections of human renin. Thus decreases to normotension occurred in the passive administration experiments with maximum antirenin titers as low as 0.7 A.U./ml to human renin,* while decreases toward normotension during active therapy were never *Our preparations of antirenin to human renin contained variable amounts of antirenin to hog reniu as a contaminant, having been obtained from animals previously injected with hog renin. greater than fifty per cent. "With one exception,f the animals in this group appeared entirely well during the initial passive treatment experiments. A representative experiment is shown in figure 2a.
Although these observations manifest a rough correlation between the maximum titer of antirenin to human renin and the extent of the antihypcrtensive effects, statistical analysis of the data did not suggest a linear relationship between these two variables. On the other hand the overall association between the antihypertensive responses and the presence of antirenin to human renin in the plasma was highly significant (P = 0.002). 1 Minimal blood pressure decreases in response to administration of antirenin to human renin occurred even in normotensive monkeys. Two such experiments are summarized in the lowest portion of table 2.
2. Normal dog serum and antirenin to hog renin. The initial experiments in this cate-tMonkey 32, which received the largest volume of dog serum given in any of the initial experiments (table 2) , was anorexic during the first two days after serum and struggled slightly less than usually when taken from the cage on the fifth day for determination of blood pressure. Passive treatment of experimental renal hypertension icith antirenin. The dose schedule of diphenhydramine hydrocliloride is given in the text. See tinder figure 1 for explanation of symbols.
gory gave negative results. These experiments, shown in the middle portion of table 2, failed to suggest any effect on blood pressure although maximum titers of antirenin to hog renin as high as 19 A.U./ml were obtained. With one exception,* the animals in this group appeared normal in every respect during the experiment.
Two initial experiments in which 10 and 15 ml/kg of normal dog serum were given to normotensive monkeys are shown in the lowest portion of table 2. The results in these monkeys were negative.
3. Sensitization. Nine of the initial experiments in hypertensive monkeys were followed after several months by experiments with normal dog serum intended as controls. In six cases variable decreases in blood pressure occurred (examples in fig. 2a and b), two associated with transient minor signs such as facial pallor, abdominal distention, and easy fatigability and four associated with severe clinical collapse in a picture indistinguishable from that seen in monkeys after an intravenous injection of histamine. 14 Subsequent experiments indicated that the blood pressure changes and clinical signs were due to sensi-*The experiment in monkey 39 was considered negative in view of the nigh standard deviation of the control blood pressure determinations and the fact that this animal was pale during the week after serum, with a distended abdomen. tization of the monkeys to dog serum. Two of the animals which had shown clinical signs and marked blood pressure decreases in response to 3.0 ml/kg of normal dog serum failed to manifest such changes when an antihistamine was administered during the experimental period ( fig. 2b ).*
The conclusion that the blood pressure decreases in our initial dog serum experiments were due specifically to the presence of antirenin rests on a comparison between the eight experiments in which the dog serum contained this antibody and the six experiments in which it was absent. There is no reason to believe that the blood pressure decreases in the presence of antirenin to human renin were related to sensitivity phenomena. Two experiments with antirenin to human renin in which the antihistamine was administered concurrently failed to reveal any ability of the antihistamine to prevent the blood pressure decrease due to antirenin ( fig. 2b ).
Prophylaxis of Experimental Renal Hypertension
Attempts to protect monkeys against the development of experimental renal hypertension by producing a titer of antirenin before constriction were made in the light of our previous finding 2 that dogs are protected com- pletely against hypertension by an appropriate titer of antirenin to hog renin at the time of the constriction. Both in this work and in the earlier work on dogs the criterion indicating "complete protection" was maintenance of normotension for one month or longer after the second renal artery constriction. Attempts to protect against the development of hypertension after constriction in monkeys were made with preparations of human, hog, and dog renin.
Crude Human Benin. In contrast to thirteen untreated control monkeys which developed hypertensions of 20-50 mm Hg after unilateral (right renal artery) constriction and 31-63 mm Hg after the second (left renal artery) constriction ( fig. 3c ), hlood pressure changes were minimal in three monkeys in which we were able to maintain titers of 0.4 A.U./ml or over to human renin during the experimental period ( fig. 3a) . Figure 4a illustrates the tendency observed in these ex-periments for blood pressure to rise substantially after the drop in antirenin titer resulting from discontinuance of renin injections. In two prophylaxis experiments, such as the one illustrated in figure 4c, titers could not be maintained with the quantities of human renin available and protection was entirely absent.
Three of the five prophylaxis monkeys received human renin from cortex. The other two received human renin prepared from the whole kidney. There was no evidence to suggest that the degree of protection against the development of hypertension depended in any way on the source of the renin. Monkeys of relatively small size (2.5-5.4 kg) were selected for these experiments in order to conserve human renin and all except one of the five were female. None of the animals lost weight between constrictions.
Although these results are suggestive, additional prophylaxis experiments would be nec- essary to establish the role of renin during the development of experimental renal hypertension in the monkey. It would be desirable to know if higher titers of antirenin to human renin in a group of monkeys would protect completely against hypertension, especially after constriction of both renal arteries. Crude Infraprimate Rewins. Two monkeys injected daily with crude hog renin from cortex and two monkeys injected with crude dog renin from cortex developed hypertensions after constriction of the right renal artery, which became more marked after constriction of the left renal artery. The magnitude of the hypertensions and the time course of their development did not differ from corresponding features of hypertension in the control group.
These experiments therefore failed to provide any evidence for a nonspecific effect of foreign protein against the development of renal hypertension or for any direct antihypertensive activity in the crude renal extracts. The duration of injections and the maximum daily doses of renin and of foreign protein were comparable to those used in the prophylaxis experiments with crude human renin.
Semipurified Hog Benin from Cortex. In six out of eight monkeys injected daily with maximum daily doses of 2 to 20 D.U./kg of semipurified hog renin from cortex, hypertension developed after constriction of the right renal artery, although titers as high as 25 A.U./ml were present at the time of constriction. The development of hypertension FRANK in a representative animal given semipurified hog renin is shown in figure 4b , where it may be compared with the record of a control animal in figure 4d .
One of the two monkeys in which hypertension did not develop after the initial constriction had been injected daily during a previous experiment 1 with a very crude preparation of human renin, without the appearance of antibodies. Taken as a whole, however, the magnitudes of the hypertensions developing after unilateral constriction in the animals injected with semipurified hog renin ( fig. 3b ) were similar to the corresponding hypertensions observed in the untreated control group (fig. 3c ).
Hypertension was present in all these animals after the second renal artery constriction in spite of titers to hog renin as high as 23 A.U./ml at the time of constriction. The development of hypertension in monkeys injected with semipurified hog renin (summary in fig. 3b ) was similar to the development of hypertension in untreated control animals (summary in fig. 3e ). These experiments thus failed to support the possibility of any antihypertensive effects due to a high titer of antirenin which could not be predicted on the basis of the known cross-neutralization reactions between renin and antirenin.
CLINICAL, PATHOLOGIC, AND OTHER OBSERVATIONS
Although the most hardy of the simians, the rhesus is more susceptible than the dog to the morbid effects of hypertension and to diseases occurring in the laboratory. The natural deaths in our colony due to renal artery constriction, hypertension or the injection of toxic substances are discussed below. The deaths not related to the experimental program were due chiefly to tuberculosis, which accounted for twenty-three animals.
Deaths Related to Renal Artery Constriction
Sixteen monkeys died from causes related to the production of renal hypertension, including three from mishaps during surgery. Three animals died with indications of severe gastrointestinal disturbance within two weeks to two months after the second constriction.
Gross hemorrhages in the heart and along the gastrointestinal tract were a prominent finding in seven of the monkeys. In only two animals (no. 12 and 37), however, could arterioloneerosis be demonstrated histologically. In three others the arterioles appeared normal, while tissue sections from the remaining two animals were not available for examination. A review of our records revealed that one of the proven cases of malignant hypertension had occurred in a monkey (no. 12) in which the constriction of the renal artery on the second side, as measured in millimeters, had been more severe than the constrictions in other animals of the same body weight category. Thus, only one proven ease of malignant hypertension was observed in thirtyfive monkeys made hypertensive by bilateral 3:1 renal artery constriction, or unilateral constriction followed by contralateral nephrectomy.
Varying degrees of pulmonary edema, hydrothorax, ascites, facial edema and edema of the dependent subcutaneous tissues were found in twelve of the animals. 1 Six of these monkeys showed cardiac hypertrophy. Two animals, with severe pulmonai-y edema, had hearts of nearly twice the normal weight.* The monkey with the most severe hypertension in the colony (220 mm Hg) also had the most severe cardiac hypertrophy (heart weight of 69 g in a 9.3 kg animal). Pigmentladen macrophages were found on histological examination of lung tissue sections from this animal. In four animals definite cardiac hypertrophy was found to be associated with moderate to severe pulmonary edema, and moderate to severe hypertension. Pigmentladen macrophages in the lung tissue sections of one animal indicated a degree of pulmonary congestion although gross pulmonary edema did not occur. Signs of congestive heart failure appeared in seven of the fifty-*The organs weighed at autops3 r were taken from animals of widely varying stages of development. Organ weights were interpreted by comparison with normal organ weights reported in the literature for animals in various body weight categories. 15 
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Two monkeys died suddenly one week and eight weeks after the second renal artery constriction. Both animals had appeared normal during the entire postoperative period. Except for postmortem blood urea nitrogen levels of 123 and 250 mg/100 ml respectively. autops3 r findings were negative.
Morbid Effects of Hypertension
Some degree of cardiac hypertrophy was present in every one of ten renal hypertensive monkeys in good health which were sacrificed at the conclusion of the experiments. In six monkeys with blood pressures of 178 to 195 mm Hg the hearts weighed from 120% to 215% of the mean heart weight for animals in the same body weight category. In four monkeys with blood pressures of 144 to 161 mm Hg the hearts weighed from 110% to 130% of the means for normal animals. There was no evidence of a relationship between the duration of hypertension and the degree of hypertrophy. Pulmonary edema was not observed in these animals.
Atherosclerotic lesions, which were minimal in the normotensive monkeys, were considerably more, widespread in the hypertensive animals. The atherosclerotic findings have been described in a separate report. 17
Possible Nephrotoxie Side Effects of Treatment
Although repeated injections of crude or semipurified renin prepared from hog kidneys do not cause nephrotoxie effects in dogs, 2 some degree of antiserum nephritis in the monkeys was considered to be a definite possibility since renins and other renal proteins from human and monkey are similar immunologically. This possibility was not confirmed by our examination of numerous urine samples or by histologic study of postmortem kidney sections.
Proteinuria was present in some animals during the week following initial administration of dog serum containing antirenin to human renin. During the week following the second administrations of antiserum, proteinuria was more pronounced and cylindruria Circulation Research, Volume XII. March 1963 was observed in a few instances. The extent of proteinuria and cylindruria in different animals suggested a relationship with the dosage of dog serum, but not with the quantity of antirenin administered. Examination of urine obtained directly from the bladders of seventeen monkeys at the time of sacrifice supported this conclusion.
Histologic changes of glomerulonephritis, which have been well described in the monkey, 18 were not observed in any ol the animals sacrificed after the conclusion of the experiments. The three monkeys which had received the largest total doses of antirenin to human renin showed scattered foci of lymphocytes. The kidneys of those monkeys which had received the largest total doses of human renin, appeared entirely normal.
Effect of Renal Artery Constriction and Antirenin Titer on Renal Renin Concentration
No renin was detected in the kidneys of two normotensive monkeys in good health (no. 52 and 54) which were sacrificed after the conclusion of the experiments. A third normotensive monkey (no. 53) had renin concentrations of 0.2 and 0.5 D.U./g in the two kidneys.
In fourteen of nineteen renal artery constricted kidneys of otherwise healthy hypertensive monkeys the renin concentration was within the concentrations observed in the three normotensive monkeys. On the other hand, the renin concentration of the other four varied from 0.6 D.U./g to 2.8 D.U./g. There was no correlation evident between the renal renin concentrations and the duration or magnitude of hypertension, the degree of renal artery constriction, or the degree of renal atrophy after constriction.
Renin was not detected in the four contralateral kidneys which were removed three weeks after unilateral 3:1 renal artery constriction. When monkey 18 was sacrificed after nineteen months of hypertension produced by unilateral constriction, renin was not detected in the untouched kidney.
The kidneys of monkey 47 (sudden death in uremia, vide supra) contained 2,0 and 28 FRANK D.U. of renin per gram. This monkey had a plasma antirenin titer of 3.3 A.U./ml to human renin at the time of death. Monkey 55 (which died a few hours postoperatively due to aspiration of regurgitated fluid) was found to have only one kidney. There was an antirenin titer in this animal of 8 A.U./ml to human renin at the time of death, and the kidney contained 2.8 D.U. of renin per gram.
Discussion
The results of these experiments support the hypothesis that renin or a closely related protein is implicated in the pathogenesis of experimental renal hypertension in the monkey. These results differ in certain respects from those which have been obtained in the dog, but the basic finding in the two species is the same: Neutralization of endogenous renin is associated with antihypertensive responses. In the monkey, the association is highly significant in the treatment experiments, but only suggestive in the prophylaxis experiments.
One distinguishing feature between the monkey and the dog is the substantially lower plasma concentration of antirenin necessary to produce minimal antihypertensive effects. The minimum effective titers were higher in the dog both during active 2 and passive 3 treatment. This feature, together with the related observation that the normal average renal renin concentration is considerably higher in the dog than in the monkey, 19 ' 20 might reflect a greater sensitivity of the monkey to the effects of renin. It is also possible that these differences are not meaningful, inasmuch as they depend on a bioassay method which involves one of the species concerned, the dog.
A second distinguishing feature between the monkey and the dog is to be found in their differing responses to active treatment of experimental renal hypertension with renin. Although both species reveal a high correlation between the appearance of antirenin in the plasma and manifestation of antihypertensive responses, the monkey differs from the dog in that its blood pressure decreases do not extend further than halfway to normo-tension and do not reveal any relationship between the magnitude of the antirenin titer and the degree of the antihypertensive response.
There are indications in both the monkey and the dog of compensation against the effects of antirenin circulating in the blood for long periods of time. Thus, the minimum titer of antirenin necessary to produce minimal antihypertensive effects is higher during active therapy than in passive therapy, 2 A.U./ml as compared with 1 A.U./ml in the dog 3 and 0.8 A.U./ml as compared with 0.2 A.U./ml in the monkey.
It has been shown that the renin concentration of the kidneys of renin injected dogs 20 increases as the antirenin titer increases. Similarly, high renin concentrations in two monkeys sacrificed with a titer of antirenin to human renin are reported in this paper. Such compensatory changes may account for the inability in these experiments to treat experimental renal hypertension in the monkey with more than partial success.
During the four treatment experiments with human renin reported here the titer began to decrease (and the blood pressure showed a tendency to rise) within four to six weeks after injections were begun, although the renin dose level was maintained. Such changes were never observed in dogs.
A final distinguishing feature between the monkey and the dog is the greater susceptibility of the former to hypertension. As indicated previously, the elevation of blood pressure after unilateral 3:1 constriction was maintained during the entire period of observation (19 to 35 months) in four out of five monkeys. Similarly, hypertension has been found not infrequently in humans "with unilateral renal disease. In dogs, on the other hand, persistence of hypertension after unilateral constriction is the exception rather than the rule. Schroeder 21 found that approximately two-thirds of dogs return to normotension within a year after constriction of one renal artery to a point at which 75% of the lumen is occluded.
Ogden and his associates 22 ored to prove that central regulatory mechanisms assume the burden of maintaining the blood pressure at an elevated level as renal hypertension becomes chronic. Since the outstanding features of primate evolution are an increasing relative size and complexity of the cerebral cortex, 24 -25 and an increasing predominance of cerebral control over bodily functions, 26 Ogden's concept deserves further study as a hypothesis which might explain the tendency for the monkey to maintain its hypertension under circumstances in which the dog does not. Finally, the preliminary findings of Johnson and Browne 27 suggest that the cerebral cortex exerts a more profound role on the course of experimental renal hypertension in the monkey than in the dog. These workers found blood pressure decreases in monkeys but not in dogs after excision of certain cortical areas. Our findings suggest that experiments with antirenin to human renin would be feasible in human beings with essential hypertension. In view of the negative urinary and histological findings obtained during the present study, antiserum nephritis would probably not be a complication. In such experiments passive administration of dog serum containing antirenin to human renin, in a dose of 150 A.U./kg, might be expected to produce an antirenin titer of 1 A.U./ml of serum. The most potent antiserum containing antirenin to human renin which we prepared had a titer of 40 to 50 A.U./ml. Therefore, in order to administer the desired dose of antirenin as unfractionated serum, it would be necessary to inject approximately 4 ml/kg of dog serum. The method of antirenin purification used during the present study, reported elsewhere, 1 would reduce the total protein by approximately half and further purification would be desirable and attainable. Allowing for 75% loss of antirenin during purification, an estimated 200,000 A.U. of antirenin to human renin would be necessary to carry out six experiments in the human.
Treatment of human essential hypertension with monkey renin is a theoretic possibility, but the amounts of renin necessary for a sin-
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gle experiment would be almost prohibitive in terms of the number of monkey kidneys necessary. In order to inject a 50 kilogram human subject daily for three months with 10 D.U./kg of monkey renin, approximately 45,000 D.U. would be required. At an average kidney weight of eight grams and an average yield of 0.1 D.U. of renin per gram of tissue, approximately 56,000 monkey kidneys would be required for a single experiment, without allowing for any loss during purification of the monkey renin. One might anticipate that if passive immunization experiments in human essential hypertension proved successful, protein chemists and immunologists might be stimulated to study the renin molecule and undertake possible modification of the antigenicity of hog renin so that its antirenin would neutralize human renin. A more feasible approach, however, to the possible pathogenetic role of renin in essential hypertension might be the production of an "antimetabolite" to angiotensin. Summary 1. Monkey renin and human renin, but not hog, dog, or rabbit renins, were pressor in the monkey. Monkey renin was neutralized by antirenin to human renin, but not by antirenin to hog renin or antirenin to dog renin.
2. Experimental renal hypertension developed consistently in the monkey after unilateral 3:1 renal artery constriction and became more marked after contralateral constriction or nephrectomy. Hypertension usually persisted when the second kidney was left untouched.
3. Chronic experimental renal hypertension in the monkey was treated with partial success by crude human renin. Semipurified hog renin was not therapeutically effective.
4. Chronic experimental renal hypertension was treated successfully by passive administration of dog 1 serum containing antirenin to human renin, but not by dog serum containing antirenin to hog renin or dog serum without antirenin.
5. Prophylaxis of experimental renal hypertension with crude human renin was par-254 FRANK tially successful in preliminary experiments.
6. Attempts to alter the antigenieity of hog renin through chemical treatment so that the antibody to it would neutralize human renin were not successful. Antihypertensive effects were not observed during treatment or prophylaxis experiments with chemically treated semipurified hog renin.
7. The interfering effects of renal medulla seen in the treatment of renal hypertension in dogs with hog renin were not observed in monkeys treated with human renin.
8. During each individual experiment involving treatment of the renal hypertensive monkey with human renin, correlation was observed between the extent of the antihypertensive response and the antirenin titcr to human renin. On the other hand, correlation was not apparent when the antihypertensive responses and tlie maximum antirenin titers of different experiments were compared. However, rough correlation between antihypertensive responses and maximum antirenin titers was observed in passive administration experiments with antirenin to human renin. 9. Passive administration of dog serum containing antirenin to human renin to renal hypertensive monkeys was followed by antihypertensive responses which were substantially more marked than in monkeys in which comparable antirenin titers were produced by daily injections of human renin. Passive administration of normal dog serum or dog serum containing antirenin to hog renin was not followed by decreases in blood pressure during initial experiments with dog serum. Sensitization to dog serum was a complicating feature of passive administration experiments after the initial experiment.
10. With both active and passive treatment, the minimum titers of antirenin to human renin required for minimal antihypertensive responses in the monkey were lower than the minimum effective titers of antirenin to hog renin observed previously in dogs.
11. The chief postoperative complication after renal artery constriction in the monkey was congestive heart failure. Malignant hypertension with necrotizing arteriolar lesions occurred infrequently. Atherosclerosis and cardiac hypertrophy were common findings after a year or more of hypertension. Arteriolar lesions were absent or minimal. Significant nephrotoxic effects did not appear to result from daily injections of crude human renin or from passive administration of dog serum containing antirenin to human renin.
12. These results support the hypothesis that renin (or a closely related protein) plays a role in the pathogenesis of primate experimental renal hypertension.
13. Passive administration experiments with antirenin to human renin to determine the possible role of renin in the pathogenesis of essential hypertension are a practical possibility.
